|
US5360897A
(en)
*
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
|
KR900000546B1
(ko)
*
|
1985-03-10 |
1990-01-31 |
데이진 가부시키가이샤 |
녹농균의 E 87 Ag 항원 및 그것에 대한 모노클로날 항체 및 하이브리도마
|
|
IT1187753B
(it)
*
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
DK163176C
(da)
*
|
1985-09-27 |
1992-06-22 |
Schweiz Serum & Impfinst |
Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen
|
|
US4755381A
(en)
*
|
1986-03-27 |
1988-07-05 |
Swiss Serum And Vaccine Institute Berne |
Klebsiella capsular polysaccharide vaccine
|
|
US4789544A
(en)
*
|
1986-05-23 |
1988-12-06 |
Midcon Labs. Inc. |
Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
|
|
DE3727987A1
(de)
*
|
1987-08-21 |
1989-03-02 |
Sleytr Uwe B |
Pharmazeutische struktur
|
|
US5043158A
(en)
*
|
1987-08-21 |
1991-08-27 |
Chembiomed, Ltd. |
Immunogenic compositions containing ordered carriers
|
|
US5063054A
(en)
*
|
1988-04-18 |
1991-11-05 |
Joseph Chang |
Microbial products used for treatment of hepatitis
|
|
NZ239643A
(en)
*
|
1990-09-17 |
1996-05-28 |
North American Vaccine Inc |
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
|
|
US5153312A
(en)
*
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
FR2682388B1
(fr)
*
|
1991-10-10 |
1995-06-09 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
|
|
WO1993013797A2
(en)
*
|
1992-01-16 |
1993-07-22 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
|
|
US5554730A
(en)
*
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
|
US5695768A
(en)
*
|
1995-06-07 |
1997-12-09 |
Alberta Research Council |
Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
|
|
US5866132A
(en)
*
|
1995-06-07 |
1999-02-02 |
Alberta Research Council |
Immunogenic oligosaccharide compositions
|
|
US6477464B2
(en)
|
2000-03-09 |
2002-11-05 |
Donnelly Corporation |
Complete mirror-based global-positioning system (GPS) navigation solution
|
|
US6693517B2
(en)
|
2000-04-21 |
2004-02-17 |
Donnelly Corporation |
Vehicle mirror assembly communicating wirelessly with vehicle accessories and occupants
|
|
US6329925B1
(en)
|
1999-11-24 |
2001-12-11 |
Donnelly Corporation |
Rearview mirror assembly with added feature modular display
|
|
ES2308844T3
(es)
|
1998-07-15 |
2008-12-01 |
The Brigham And Women's Hospital, Inc. |
Vacuna de polisacaridos para infecciones estafilococidas.
|
|
CN1263510C
(zh)
*
|
1998-08-19 |
2006-07-12 |
巴克斯特健康护理股份有限公司 |
多糖-蛋白质缀合物或寡糖-蛋白质缀合物、其制备方法及其应用
|
|
US7167796B2
(en)
|
2000-03-09 |
2007-01-23 |
Donnelly Corporation |
Vehicle navigation system for use with a telematics system
|
|
US7370983B2
(en)
|
2000-03-02 |
2008-05-13 |
Donnelly Corporation |
Interior mirror assembly with display
|
|
AU2002251807A1
(en)
|
2001-01-23 |
2002-08-19 |
Donnelly Corporation |
Improved vehicular lighting system for a mirror assembly
|
|
US7581859B2
(en)
|
2005-09-14 |
2009-09-01 |
Donnelly Corp. |
Display device for exterior rearview mirror
|
|
US7255451B2
(en)
|
2002-09-20 |
2007-08-14 |
Donnelly Corporation |
Electro-optic mirror cell
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
WO2003094961A1
(en)
*
|
2002-05-09 |
2003-11-20 |
Massimo Porro |
Improved polysaccharide and glycoconjugate vaccines_____________
|
|
US7310177B2
(en)
|
2002-09-20 |
2007-12-18 |
Donnelly Corporation |
Electro-optic reflective element assembly
|
|
HUE047780T2
(hu)
|
2002-10-11 |
2020-05-28 |
Glaxosmithkline Biologicals Sa |
Polipeptid vakcinák hipervirulens meningokokkusz vonalak elleni széles-spektrumú védelemre
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
ES2411080T3
(es)
|
2003-01-30 |
2013-07-04 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
EP1961426B1
(de)
|
2003-10-02 |
2011-04-27 |
Novartis Vaccines and Diagnostics S.r.l. |
Kombinationsimpfstoffe gegen Meningitis
|
|
WO2005044861A1
(en)
*
|
2003-10-31 |
2005-05-19 |
Wyeth Holdings Corporation |
Polysaccharides of helicobacter pylori
|
|
JP2007519746A
(ja)
*
|
2004-01-29 |
2007-07-19 |
バイオシネクサス インコーポレーティッド |
ワクチン調製におけるアミノ−オキシ官能基の使用
|
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
EP2272531A3
(de)
|
2004-04-30 |
2011-04-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Integration von Meningokokkenkonjugatimpfstoff
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
|
US8246993B2
(en)
*
|
2004-06-10 |
2012-08-21 |
Cytogel Pharma, Llc |
Advantageous hydrogel composition
|
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
|
US20060013886A1
(en)
|
2004-06-28 |
2006-01-19 |
Daqing Wu |
Injectable microspheres
|
|
EP1791967B1
(de)
|
2004-09-21 |
2013-11-27 |
The Brigham And Women's Hospital, Inc. |
Verfahren und zusammensetzungen in verbindung mit mannuronsäurespezifischen bindungspeptiden
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
ES2670231T3
(es)
|
2006-03-22 |
2018-05-29 |
Glaxosmithkline Biologicals S.A. |
Regímenes para inmunización con conjugados meningocócicos
|
|
GB0605757D0
(en)
|
2006-03-22 |
2006-05-03 |
Chiron Srl |
Separation of conjugated and unconjugated components
|
|
GB0612854D0
(en)
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
|
PT2097102E
(pt)
|
2006-09-07 |
2012-08-03 |
Glaxosmithkline Biolog Sa |
Vacina de combinação tendo quantidades reduzidas de antigénio de poliovírus
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
JP2010525035A
(ja)
|
2007-05-02 |
2010-07-22 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
GB0713880D0
(en)
*
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
US8017898B2
(en)
|
2007-08-17 |
2011-09-13 |
Magna Electronics Inc. |
Vehicular imaging system in an automatic headlamp control system
|
|
US8446470B2
(en)
|
2007-10-04 |
2013-05-21 |
Magna Electronics, Inc. |
Combined RGB and IR imaging sensor
|
|
PT2200642E
(pt)
|
2007-10-19 |
2012-05-30 |
Novartis Ag |
Formulações de vacinas meningocócicas
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
RU2475496C2
(ru)
|
2008-02-21 |
2013-02-20 |
Новартис Аг |
МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
|
|
PT2349520T
(pt)
|
2008-10-27 |
2016-08-16 |
Glaxosmithkline Biologicals Sa |
Método de purificação para hidrato de carbono de estreptococos grupo a
|
|
GB0822633D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
EP2367568A2
(de)
|
2008-12-17 |
2011-09-28 |
Novartis AG |
Meningokokken-impfstoffe mit hämoglobin-rezeptor
|
|
NZ595291A
(en)
|
2009-03-24 |
2013-08-30 |
Novartis Ag |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
|
CA2756522C
(en)
|
2009-03-24 |
2018-06-26 |
Novartis Ag |
Adjuvanting meningococcal factor h binding protein
|
|
WO2010119343A2
(en)
|
2009-04-14 |
2010-10-21 |
Novartis Ag |
Compositions for immunising against staphylococcus aureus
|
|
US8647621B2
(en)
|
2009-07-27 |
2014-02-11 |
Fina Biosolutions, Llc |
Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
|
|
BR112012004275A2
(pt)
|
2009-08-27 |
2016-11-16 |
Novartis Ag |
polipeptídios híbridos incluindo sequências meningocócicas de fhbp
|
|
WO2011030218A1
(en)
|
2009-09-10 |
2011-03-17 |
Novartis Ag |
Combination vaccines against respiratory tract diseases
|
|
EP2483390A2
(de)
|
2009-09-30 |
2012-08-08 |
Novartis AG |
Expression von meningokokken-fhbp-polypeptiden
|
|
BR112012009014B8
(pt)
|
2009-09-30 |
2022-10-04 |
Novartis Ag |
Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
|
|
CA2779816A1
(en)
|
2009-10-27 |
2011-05-05 |
Novartis Ag |
Modified meningococcal fhbp polypeptides
|
|
WO2011051917A1
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
|
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
|
SG181750A1
(en)
|
2009-12-17 |
2012-07-30 |
Fina Biosolutions Llc |
Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
|
AU2011255258B2
(en)
|
2010-05-21 |
2015-07-09 |
Cytogel Pharma, Llc |
Materials and methods for treatment of inflammation
|
|
US10478483B2
(en)
|
2010-06-25 |
2019-11-19 |
Glaxosmithkline Biologicals Sa |
Combinations of meningococcal factor H binding proteins
|
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
|
EP2655389A2
(de)
|
2010-12-24 |
2013-10-30 |
Novartis AG |
Verbindungen
|
|
CA2828844C
(en)
|
2011-03-02 |
2020-07-14 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
GB201114923D0
(en)
|
2011-08-30 |
2011-10-12 |
Novartis Ag |
Immunogenic proteins and compositions
|
|
AU2012335208B2
(en)
|
2011-11-07 |
2017-08-31 |
Glaxosmithkline Biologicals S.A. |
Carrier molecule comprising a spr0096 and a spr2021 antigen
|
|
RS56709B1
(sr)
|
2011-12-06 |
2018-03-30 |
Valneva Austria Gmbh |
Jedinjenja aluminijuma za primenu u terapeuticima i vakcinama
|
|
GB201121301D0
(en)
|
2011-12-12 |
2012-01-25 |
Novartis Ag |
Method
|
|
AU2011384634A1
(en)
|
2011-12-29 |
2014-06-19 |
Novartis Ag |
Adjuvanted combinations of meningococcal factor H binding proteins
|
|
CN104519910B
(zh)
|
2012-03-07 |
2017-05-03 |
诺华股份有限公司 |
肺炎链球菌抗原的含佐剂制剂
|
|
JP2015509963A
(ja)
|
2012-03-08 |
2015-04-02 |
ノバルティス アーゲー |
Tlr4アゴニストを含む混合ワクチン
|
|
WO2014013375A1
(en)
|
2012-07-16 |
2014-01-23 |
Pfizer Inc. |
Saccharides and uses thereof
|
|
CN104602705A
(zh)
|
2012-09-06 |
2015-05-06 |
诺华股份有限公司 |
血清组b脑膜炎球菌和d/t/p的联合疫苗
|
|
BR112015007126A2
(pt)
|
2012-10-02 |
2017-08-08 |
Glaxosmithkline Biologicals Sa |
composição, método para induzir uma resposta imune, e, uso de uma composição
|
|
EP3620172A1
(de)
|
2012-10-12 |
2020-03-11 |
GlaxoSmithKline Biologicals SA |
Unvernetzte azelluläre pertussis-antigene zur verwendung in kombinationsimpfstoffen
|
|
HRP20180039T1
(hr)
|
2012-11-30 |
2018-04-06 |
Glaxosmithkline Biologicals S.A. |
Antigeni pseudomonasa i kombinacije antigena
|
|
ES2670863T3
(es)
|
2013-02-01 |
2018-06-01 |
Glaxosmithkline Biologicals Sa |
Administración intradérmica de composiciones inmunológicas que comprenden agonistas del receptor de tipo Toll
|
|
WO2015082501A1
(en)
*
|
2013-12-03 |
2015-06-11 |
Virometix Ag |
Proline-rich peptides protective against s. pneumoniae
|
|
SG10201907875TA
(en)
|
2014-02-28 |
2019-09-27 |
Glaxosmithkline Biologicals Sa |
Modified meningococcal fhbp polypeptides
|
|
EP3034516A1
(de)
|
2014-12-19 |
2016-06-22 |
Novartis AG |
Reinigung von Streptokokkenkapselpolysaccharid
|
|
US12109259B2
(en)
|
2016-09-02 |
2024-10-08 |
Glaxosmithkline Biologicals Sa |
Vaccines for Neisseria gonorrhoeae
|
|
US20210108002A1
(en)
|
2016-12-06 |
2021-04-15 |
Glaxosmithkline Biologicals Sa |
Purification Process For Capsular Polysaccharide
|
|
CN111065417B
(zh)
|
2017-06-23 |
2024-04-19 |
美商艾芬尼维克斯公司 |
免疫原性组合物
|
|
US10975121B2
(en)
|
2017-06-24 |
2021-04-13 |
Cytogel Pharma, Llc |
Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
|
|
EP3607967A1
(de)
|
2018-08-09 |
2020-02-12 |
GlaxoSmithKline Biologicals S.A. |
Modifizierte meningokokken fhbp polypeptide
|
|
EP3799884A1
(de)
|
2019-10-01 |
2021-04-07 |
GlaxoSmithKline Biologicals S.A. |
Immunogene zusammensetzungen
|
|
GB202013262D0
(en)
|
2020-08-25 |
2020-10-07 |
Glaxosmithkline Biologicals Sa |
Vaccine Composition
|
|
GB202208089D0
(en)
|
2022-06-01 |
2022-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
GB202208093D0
(en)
|
2022-06-01 |
2022-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|